SEC Tracker
Get the app

Cardiff Oncology CRDF

Cardiff Oncology reports no ownership

Leila Alland, new insider at CRDF

Form
3
Filed
Importance
Routine
  1. No securities owned
  2. Filer: Leila Alland
  3. Position: Chief Medical Officer

Written from the Form 3 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Cardiff Oncology files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Silence Therapeutics SLN public float $206M, Jun 30, 2025
  2. Rezolute RZLT public float $204M, Dec 31, 2025
  3. Tvardi Therapeutics TVRD public float $207M, Jun 30, 2025
  4. Natures Sunshine Products NATR public float $211M, Jun 30, 2025
  5. Rocket Pharmaceuticals RCKT public float $213M, Jun 30, 2025